Motilal Oswal India Business Excellence Fund IV
Motilal Oswal India Business Excellence Fund IV is a closed India-focused growth-equity vehicle backing mid-market companies. Public records directly identify Pathkind Diagnostics, Simpolo Vitrified, Niva Bupa Health Insurance and VVDN Technologies in IBEF IV-related transactions, giving demand-side advisers a vehicle-specific view separate from the manager’s Fund V and real-estate or credit strategies.
At a glance
- Founded
- 2022
- Footprint
- Mumbai
- Stage
- Growth private equity; mid-market Indian businesses
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Motilal Oswal India Business Excellence Fund IV uses a growth private equity; mid-market indian businesses approach across Consumer, financial services, life sciences, manufacturing.
Current evidence
Motilal Oswal’s current private-equity page continues to identify IBEF IV as a 2022 US$550 million fund with 13 investments, while the group’s 2024–25 annual report and current private-equity platform provide vehicle context. Issuer and regulatory records preserve the attributable IBEF IV positions in Pathkind, Simpolo, Niva Bupa and VVDN.
Strategy
Growth private equity; mid-market Indian businesses
Sector focus
Consumer, financial services, life sciences, manufacturing
Current signal
Motilal Oswal’s current private-equity page continues to identify IBEF IV as a 2022 US$550 million fund with 13 investments, while the group’s 2024–25 annual report and current private-equity platform provide vehicle context. Issuer and regulatory records preserve the attributable IBEF IV positions in Pathkind, Simpolo, Niva Bupa and VVDN.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.